CMG-101

N/A

Report date: 2025/01/26 16:35:00
NME

Base Information

Drug NameCMG-101
Drug Alias NamemTOR 1/2 kinase inhibitor (CHA University)CMG-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMammalian target of Rapamycin (mTORC1) inhibitorsmTOR Complex 2 inhibitors
TargetsmTOR Complex 2Mammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCha University
China Registration ClassN/A

Develop Information

Active CompaniesCha University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A